A detailed history of Fil LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fil LTD holds 4,003,519 shares of BMY stock, worth $232 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,003,519
Previous 752,951 431.71%
Holding current value
$232 Million
Previous $31.3 Million 562.56%
% of portfolio
0.2%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $129 Million - $168 Million
3,250,568 Added 431.71%
4,003,519 $207 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $18.5 Million - $24.4 Million
-460,243 Reduced 37.94%
752,951 $31.3 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $310 Million - $352 Million
-6,467,971 Reduced 84.21%
1,213,194 $65.8 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $5.19 Million - $6.19 Million
107,009 Added 1.41%
7,681,165 $394 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $16.4 Million - $18.4 Million
-284,153 Reduced 3.62%
7,574,156 $440 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $151 Million - $168 Million
-2,369,363 Reduced 23.17%
7,858,309 $503 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $14.5 Million - $16.4 Million
220,578 Added 2.2%
10,227,672 $709 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $17.1 Million - $20.3 Million
250,321 Added 2.57%
10,007,094 $720 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $185,066 - $109 Million
-1,423,589 Reduced 12.73%
9,756,773 $694 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $87.9 Million - $96.9 Million
1,210,940 Added 12.15%
11,180,362 $861 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $163 Million - $195 Million
2,648,544 Added 36.18%
9,969,422 $728 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $142 Million - $166 Million
2,650,727 Added 56.76%
7,320,878 $456 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $51.1 Million - $59.8 Million
862,993 Added 22.67%
4,670,151 $276 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $6.36 Million - $6.93 Million
-102,780 Reduced 2.63%
3,807,158 $254 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $5.72 Million - $6.44 Million
-96,467 Reduced 2.41%
3,909,938 $247 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $67.6 Million - $76.6 Million
-1,170,959 Reduced 22.62%
4,006,405 $249 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $23.6 Million - $26.2 Million
411,106 Added 8.63%
5,177,364 $312 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $49 Million - $57.2 Million
893,131 Added 23.06%
4,766,258 $280 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $83.9 Million - $122 Million
-1,809,082 Reduced 31.84%
3,873,127 $216 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $126 Million - $165 Million
2,566,594 Added 82.38%
5,682,209 $365 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $124 Million - $147 Million
2,897,634 Added 1329.31%
3,115,615 $158 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $2.66 Million - $2.94 Million
-59,656 Reduced 21.49%
217,981 $9.89 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $9.18 Million - $10.9 Million
203,529 Added 274.64%
277,637 $13.2 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $121 Million - $157 Million
-2,487,496 Reduced 97.11%
74,108 $3.85 Million
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $133 Million - $150 Million
2,402,567 Added 1510.7%
2,561,604 $159 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $8.68 Million - $10.8 Million
-171,846 Reduced 51.94%
159,037 $8.8 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $11.9 Million - $13.7 Million
-198,787 Reduced 37.53%
330,883 $20.9 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $3.38 Million - $3.68 Million
-56,360 Reduced 9.62%
529,670 $32.5 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $1.97 Million - $2.27 Million
35,670 Added 6.48%
586,030 $37.4 Million
Q2 2017

Aug 29, 2017

BUY
N/A
550,360
550,360 $30.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.